Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...

Shares of Palatin Technologies, Inc. (PTN) gained 16% on Monday after the company announces completion of patient enrollment in phase ...

Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease ...

If you are experiencing hair loss, find a dermatologist who will help you address the various aspects of hair thinning ...

Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

Oral corticosteroids are anti-inflammatory medications that are the mainstay treatment for PMR. Corticosteroids, like prednisone, are highly effective, and patients often experience a significant ...

Oral presentation at ACR highlights safety and efficacy data from the Phase 1 trial of umbilical cord outer lining-derived stem cells (ULSCs) ...

WASHINGTON -- Giant cell arteritis (GCA) can be successfully treated with the oral Janus kinase (JAK) inhibitor upadacitinib ...

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ...

“Encouragingly, the 6E10 dose with extended prophylaxis also resulted in less inflammation ... including topical steroid eyedrops (difluprednate) with or without Ozurdex ® and with or without oral ...

Many people with sleep apnea benefit from oral devices that pull the lower jaw forward and hold it there, enlarging the ...

Here are five common over-the-counter drugs you should avoid when breastfeeding: The average adult experiences around two or ...